Current position:Product Center > Antibodies > Biosimilar Antibodies > Anti-AAV2 mIgG2a Antibody
Anti-AAV2 mIgG2a Antibody
Product Info

Cat. NoGM-71169AB

Product:Anti-AAV2 mIgG2a Antibody



Cat. No. & Size

GM-71169AB-10           10 μg

GM-71169AB-100         100 μg

GM-71169AB-1000       1mg


Description

Species Reactivity      Human

Specificity                   Detects Adeno-associated virus

Source/Isotype           Monoclonal Mouse IgG2a

Application                 Neutralization Assay: 1.8 ng/mL-30 μg/mL

Background                Adeno-associated virus (AAV) is a non-enveloped virus that can be engineered to deliver DNA to target cells, and has attracted a significant amount of attention in the field, especially in clinical-stage experimental therapeutic strategies. The ability to generate recombinant AAV particles lacking any viral genes and containing DNA sequences of interest for various therapeutic applications has thus far proven to be one of the safest strategies for gene therapies.  The AAV2 capsid (intact particle) comprises three types of subunits, VP1, VP2, and VP3, a total of 60 copies in a ratio of 1:1:8 (VP1:VP2:VP3). This antibody recognizes a conformational epitope of assembled AAV2 capsids.

Storage                       Store at +4℃ short term (1-2 weeks). Store at -20℃ long term

Formulation               Phosphate-buffered solution, pH 7.2.

Data

GM-71169AB-1.png

Relevant data
Current position:Product Center > -- > Anti-AAV2 mIgG2a Antibody
classify
Anti-AAV2 mIgG2a Antibody
Product Info

Cat. NoGM-71169AB

Product:Anti-AAV2 mIgG2a Antibody



Cat. No. & Size

GM-71169AB-10           10 μg

GM-71169AB-100         100 μg

GM-71169AB-1000       1mg


Description

Species Reactivity      Human

Specificity                   Detects Adeno-associated virus

Source/Isotype           Monoclonal Mouse IgG2a

Application                 Neutralization Assay: 1.8 ng/mL-30 μg/mL

Background                Adeno-associated virus (AAV) is a non-enveloped virus that can be engineered to deliver DNA to target cells, and has attracted a significant amount of attention in the field, especially in clinical-stage experimental therapeutic strategies. The ability to generate recombinant AAV particles lacking any viral genes and containing DNA sequences of interest for various therapeutic applications has thus far proven to be one of the safest strategies for gene therapies.  The AAV2 capsid (intact particle) comprises three types of subunits, VP1, VP2, and VP3, a total of 60 copies in a ratio of 1:1:8 (VP1:VP2:VP3). This antibody recognizes a conformational epitope of assembled AAV2 capsids.

Storage                       Store at +4℃ short term (1-2 weeks). Store at -20℃ long term

Formulation               Phosphate-buffered solution, pH 7.2.

Data

GM-71169AB-1.png

Relevant data
Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit